Derivatives of 8-epiblechnic Acid and their Effects on Down-Regulation of Endothelin (ETA) receptor mRNA
申请人:Chan Hardy
公开号:US20100048618A1
公开(公告)日:2010-02-25
The present application discloses derivatives of 8-epiblechnic acid and use thereof in treating a disease related to endothelin receptor A or endothelin-1 (ET-1) over-expression, such as hypertension, cancer, atherosclerosis, and myocardial infarction.
本申请公开了8-epiblechnic酸的衍生物及其在治疗与内皮素受体A或内皮素-1(ET-1)过度表达相关的疾病中的应用,例如高血压,癌症,动脉粥样硬化和心肌梗死。